A Comparison of OnabotulinumtoxinA and Topiramate for the Treatment of Chronic Migraine
This multi-center pilot study compared the efficacy of onabotulinumtoxinA with topiramate (a Food and Drug Administration approved and widely accepted treatment for prevention of migraine) in individuals with chronic migraine (CM).
Length:
13:12